Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21879331 | 0.72 | LMNA (0.38) | — | |
| SCHEMBL24066870 | 0.72 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL4442945 | 0.71 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL10463 | 0.67 | — | — | |
| SCHEMBL17729837 | 0.67 | — | — | |
| SCHEMBL1306743 | 0.67 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL1116379 | 0.67 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9931 | 0.67 | — | — | |
| SCHEMBL6295216 | 0.67 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL14561703 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240335394-A1 | Use Of Methanol And Prodrugs Thereof In Therapy | LUDWIG INST FOR CANCER RES LTD (CH) | 2024-10-10 | — | — | US | claimed |
| EP-4370105-A1 | USE OF METHANOL AND PRODRUGS THEREOF IN THERAPY | Ludwig Institute for Cancer Research Ltd (CH) | 2024-05-22 | — | — | EP | claimed |
| WO-2023288299-A1 | USE OF METHANOL AND PRODRUGS THEREOF IN THERAPY | FARBER PARTNERS, LLC (US) | 2023-01-19 | — | — | WO | claimed |
| EP-0587440-A2 | Catalyst component for the polymerisation of olefins and process for preparing olefin polymers using same | NIPPON OIL COMPANY, LIMITED (JP) | 1994-03-16 | — | — | EP | claimed |
| US-20240335394-A1 | Use Of Methanol And Prodrugs Thereof In Therapy | LUDWIG INST FOR CANCER RES LTD (CH) | 2024-10-10 | — | — | US | disclosed |
| EP-4370105-A1 | USE OF METHANOL AND PRODRUGS THEREOF IN THERAPY | Ludwig Institute for Cancer Research Ltd (CH) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023288299-A1 | USE OF METHANOL AND PRODRUGS THEREOF IN THERAPY | FARBER PARTNERS, LLC (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2023288299-A1 | USE OF METHANOL AND PRODRUGS THEREOF IN THERAPY | FARBER PARTNERS, LLC (US) | 2023-01-19 | — | — | WO | disclosed |
| US-5744678-A | NICKEL COMPOUND, ORGANOPHOSPHORUS COMPOUND, ORGANOALUMINUM COMPOUND, CARBON-HALOGEN COMPOUNDS; CATALYST SELECTIVITY | NIPPON OIL CO., LTD. (JP) | 1998-04-28 | — | — | US | disclosed |
| US-5728641-A | Catalyst component for the polymerization of olefins | NIPPON OIL COMPANY, LIMITED (JP) | 1998-03-17 | — | — | US | disclosed |
| EP-0758563-A1 | OLEFIN OLIGOMERIZATION CATALYST AND PROCESS FOR THE PREPARATION OF OLEFIN OLIGOMER USING IT | NIPPON OIL COMPANY, LTD. (JP) | 1997-02-19 | — | — | EP | disclosed |
| US-5556821-A | Catalyst component for the polymerization of olefins | NIPPON OIL COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0587440-A2 | Catalyst component for the polymerisation of olefins and process for preparing olefin polymers using same | NIPPON OIL COMPANY, LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335394-A1 | Use Of Methanol And Prodrugs Thereof In Therapy | MYD88, MRGPRX2, MRGPRX1 | ALDH1A1 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.